Mac Charles (India) Ltd

NSE: BSE: 507836

₹703.10

(1.90%)

Mon, 06 Jul 2026, 01:12 pm

MTF 5xInvest in Mac Charles (India) Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)917.62

PE Ratio0

Dividend0

Finance

Real Estate Development

24.5K

Mac Charles (India) News

Mac Charles Q4 Net Profit at 108M Rupees vs Loss 198M YoY

Mac Charles (India) published audited standalone and consolidated FY26 results in newspapers per Regulation 47. Q4 standalone net profit at 107.87M rupees vs loss of 198.50M YoY; revenue at 478.04M rupees.

10 May 2026

companies

Mac Charles Q4 Net Profit at 108M Rupees vs Loss 198M YoY

Mac Charles (India) Q4 standalone net profit stood at 108M rupees vs a loss of 198M YoY, while revenue surged to 320M rupees vs 19M YoY, alongside board approvals for FY26 results and AGM.

08 May 2026

companies

Mac Charles Board Approves FY26 Results & Key Decisions

Mac Charles (India) Ltd board met on May 08, 2026, approving audited FY26 financials, AGM date, NCD redemption of Rs 50 Crore, and appointing Ernst & Young LLP as Internal Auditor.

08 May 2026

companies

Mac Charles Board Approves FY26 Results & Key Decisions

Mac Charles (India) Ltd board met on May 08, 2026, approving audited FY26 financials, AGM date, NCD redemption of Rs 50 Crore, and appointing Ernst & Young LLP as Internal Auditor.

08 May 2026

companies

Mac Charles Submits SEBI Demat Compliance Certificate

Mac Charles (India) Limited submitted its quarterly certificate under SEBI Regulation 74(5) for Q4 FY26, confirming compliance with demat processing requirements within prescribed timelines.

13 Apr 2026

companies

Showing 1–5 of 18

Rows per page:

Market Current News

SEBI Approves Rentomojo Ltd's IPO

SEBI has granted approval for Rentomojo Ltd's Initial Public Offering, marking a key regulatory milestone for the company's planned market debut.

06 Jul 2026

ipo

Concord Biotech Limited

Concord Biotech to hold 41st AGM on July 31

Concord Biotech Limited has scheduled its 41st Annual General Meeting for July 31, 2026, via video conferencing. The company has received a notice proposing the appointment of Mrs. Ekta Gupta as a Director.

06 Jul 2026

ipo

GUJARAT KIDNEY AND SUPER SPECI

Gujarat Kidney approves IPO proceeds variation

Shareholders approved the variation in the objects and terms of utilisation of the IPO proceeds. The resolution received 99.9995% votes in favour.

06 Jul 2026

ipo

SEBI Approves Manipal Health Enterprises IPO

SEBI has granted approval for Manipal Health Enterprises to proceed with its initial public offering, marking a significant milestone for the healthcare company.

06 Jul 2026

ipo

NSE Seeks RBI Nod for Quanto Cross Currency Derivatives

NSE has requested RBI approval to introduce Quanto Cross Currency Derivatives, aiming to boost exchange-traded currency volumes in India.

06 Jul 2026

currency

Showing 1–5 of 93967

Rows per page: